Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	MS evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific NX	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific NX	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific NX	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific NX	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific NX	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific NX	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific pTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific pTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	Tissue RNA - adipose tissue [NX]	Tissue RNA - adrenal gland [NX]	Tissue RNA - amygdala [NX]	Tissue RNA - appendix [NX]	Tissue RNA - basal ganglia [NX]	Tissue RNA - bone marrow [NX]	Tissue RNA - breast [NX]	Tissue RNA - cerebellum [NX]	Tissue RNA - cerebral cortex [NX]	Tissue RNA - cervix, uterine [NX]	Tissue RNA - colon [NX]	Tissue RNA - corpus callosum [NX]	Tissue RNA - ductus deferens [NX]	Tissue RNA - duodenum [NX]	Tissue RNA - endometrium 1 [NX]	Tissue RNA - epididymis [NX]	Tissue RNA - esophagus [NX]	Tissue RNA - fallopian tube [NX]	Tissue RNA - gallbladder [NX]	Tissue RNA - heart muscle [NX]	Tissue RNA - hippocampal formation [NX]	Tissue RNA - hypothalamus [NX]	Tissue RNA - kidney [NX]	Tissue RNA - liver [NX]	Tissue RNA - lung [NX]	Tissue RNA - lymph node [NX]	Tissue RNA - midbrain [NX]	Tissue RNA - olfactory region [NX]	Tissue RNA - ovary [NX]	Tissue RNA - pancreas [NX]	Tissue RNA - parathyroid gland [NX]	Tissue RNA - pituitary gland [NX]	Tissue RNA - placenta [NX]	Tissue RNA - pons and medulla [NX]	Tissue RNA - prostate [NX]	Tissue RNA - rectum [NX]	Tissue RNA - retina [NX]	Tissue RNA - salivary gland [NX]	Tissue RNA - seminal vesicle [NX]	Tissue RNA - skeletal muscle [NX]	Tissue RNA - skin 1 [NX]	Tissue RNA - small intestine [NX]	Tissue RNA - smooth muscle [NX]	Tissue RNA - spinal cord [NX]	Tissue RNA - spleen [NX]	Tissue RNA - stomach 1 [NX]	Tissue RNA - testis [NX]	Tissue RNA - thalamus [NX]	Tissue RNA - thymus [NX]	Tissue RNA - thyroid gland [NX]	Tissue RNA - tongue [NX]	Tissue RNA - tonsil [NX]	Tissue RNA - urinary bladder [NX]	Tissue RNA - vagina [NX]	Tissue RNA - B-cells [NX]	Tissue RNA - dendritic cells [NX]	Tissue RNA - granulocytes [NX]	Tissue RNA - monocytes [NX]	Tissue RNA - NK-cells [NX]	Tissue RNA - T-cells [NX]	Tissue RNA - total PBMC [NX]	Cell RNA - A-431 [NX]	Cell RNA - A549 [NX]	Cell RNA - AF22 [NX]	Cell RNA - AN3-CA [NX]	Cell RNA - ASC diff [NX]	Cell RNA - ASC TERT1 [NX]	Cell RNA - BEWO [NX]	Cell RNA - BJ [NX]	Cell RNA - BJ hTERT+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]	Cell RNA - CACO-2 [NX]	Cell RNA - CAPAN-2 [NX]	Cell RNA - Daudi [NX]	Cell RNA - EFO-21 [NX]	Cell RNA - fHDF/TERT166 [NX]	Cell RNA - GAMG [NX]	Cell RNA - HaCaT [NX]	Cell RNA - HAP1 [NX]	Cell RNA - HBEC3-KT [NX]	Cell RNA - HBF TERT88 [NX]	Cell RNA - HDLM-2 [NX]	Cell RNA - HEK 293 [NX]	Cell RNA - HEL [NX]	Cell RNA - HeLa [NX]	Cell RNA - Hep G2 [NX]	Cell RNA - HHSteC [NX]	Cell RNA - HL-60 [NX]	Cell RNA - HMC-1 [NX]	Cell RNA - HSkMC [NX]	Cell RNA - hTCEpi [NX]	Cell RNA - hTEC/SVTERT24-B [NX]	Cell RNA - hTERT-HME1 [NX]	Cell RNA - hTERT-RPE1 [NX]	Cell RNA - HUVEC TERT2 [NX]	Cell RNA - JURKAT [NX]	Cell RNA - K-562 [NX]	Cell RNA - Karpas-707 [NX]	Cell RNA - LHCN-M2 [NX]	Cell RNA - MCF7 [NX]	Cell RNA - MOLT-4 [NX]	Cell RNA - NB-4 [NX]	Cell RNA - NTERA-2 [NX]	Cell RNA - OE19 [NX]	Cell RNA - PC-3 [NX]	Cell RNA - REH [NX]	Cell RNA - RH-30 [NX]	Cell RNA - RPMI-8226 [NX]	Cell RNA - RPTEC TERT1 [NX]	Cell RNA - RT4 [NX]	Cell RNA - SCLC-21H [NX]	Cell RNA - SH-SY5Y [NX]	Cell RNA - SiHa [NX]	Cell RNA - SK-BR-3 [NX]	Cell RNA - SK-MEL-30 [NX]	Cell RNA - SuSa [NX]	Cell RNA - T-47d [NX]	Cell RNA - THP-1 [NX]	Cell RNA - TIME [NX]	Cell RNA - U-138 MG [NX]	Cell RNA - U-2 OS [NX]	Cell RNA - U-2197 [NX]	Cell RNA - U-251 MG [NX]	Cell RNA - U-266/70 [NX]	Cell RNA - U-266/84 [NX]	Cell RNA - U-698 [NX]	Cell RNA - U-87 MG [NX]	Cell RNA - U-937 [NX]	Cell RNA - WM-115 [NX]	Blood RNA - basophil [NX]	Blood RNA - classical monocyte [NX]	Blood RNA - eosinophil [NX]	Blood RNA - gdT-cell [NX]	Blood RNA - intermediate monocyte [NX]	Blood RNA - MAIT T-cell [NX]	Blood RNA - memory B-cell [NX]	Blood RNA - memory CD4 T-cell [NX]	Blood RNA - memory CD8 T-cell [NX]	Blood RNA - myeloid DC [NX]	Blood RNA - naive B-cell [NX]	Blood RNA - naive CD4 T-cell [NX]	Blood RNA - naive CD8 T-cell [NX]	Blood RNA - neutrophil [NX]	Blood RNA - NK-cell [NX]	Blood RNA - non-classical monocyte [NX]	Blood RNA - plasmacytoid DC [NX]	Blood RNA - T-reg [NX]	Blood RNA - total PBMC [NX]	Brain RNA - amygdala [NX]	Brain RNA - basal ganglia [NX]	Brain RNA - cerebellum [NX]	Brain RNA - cerebral cortex [NX]	Brain RNA - hippocampal formation [NX]	Brain RNA - hypothalamus [NX]	Brain RNA - midbrain [NX]	Brain RNA - olfactory region [NX]	Brain RNA - pons and medulla [NX]	Brain RNA - thalamus [NX]	Single Cell Type RNA - Alveolar cells type 1 [NX]	Single Cell Type RNA - Alveolar cells type 2 [NX]	Single Cell Type RNA - B-cells [NX]	Single Cell Type RNA - Basal glandular cells [NX]	Single Cell Type RNA - Basal keratinocytes [NX]	Single Cell Type RNA - Bipolar cells [NX]	Single Cell Type RNA - Cardiomyocytes [NX]	Single Cell Type RNA - Cholangiocytes [NX]	Single Cell Type RNA - Ciliated cells [NX]	Single Cell Type RNA - Club cells [NX]	Single Cell Type RNA - Collecting duct cells [NX]	Single Cell Type RNA - Cone photoreceptor cells [NX]	Single Cell Type RNA - Cytotrophoblasts [NX]	Single Cell Type RNA - Distal tubular cells [NX]	Single Cell Type RNA - Ductal cells [NX]	Single Cell Type RNA - Early spermatids [NX]	Single Cell Type RNA - Endothelial cells [NX]	Single Cell Type RNA - Enterocytes [NX]	Single Cell Type RNA - Erythroid cells [NX]	Single Cell Type RNA - Exocrine glandular cells [NX]	Single Cell Type RNA - Extravillous trophoblasts [NX]	Single Cell Type RNA - Fibroblasts [NX]	Single Cell Type RNA - Glandular cells [NX]	Single Cell Type RNA - granulocytes [NX]	Single Cell Type RNA - Hepatocytes [NX]	Single Cell Type RNA - Hofbauer cells [NX]	Single Cell Type RNA - Horizontal cells [NX]	Single Cell Type RNA - Intestinal endocrine cells [NX]	Single Cell Type RNA - Ito cells [NX]	Single Cell Type RNA - Kupffer cells [NX]	Single Cell Type RNA - Late spermatids [NX]	Single Cell Type RNA - Leydig cells [NX]	Single Cell Type RNA - Macrophages [NX]	Single Cell Type RNA - Melanocytes [NX]	Single Cell Type RNA - monocytes [NX]	Single Cell Type RNA - Mucus-secreting cells [NX]	Single Cell Type RNA - Muller glia cells [NX]	Single Cell Type RNA - Pancreatic endocrine cells [NX]	Single Cell Type RNA - Paneth cells [NX]	Single Cell Type RNA - Peritubular cells [NX]	Single Cell Type RNA - Proximal tubular cells [NX]	Single Cell Type RNA - Rod photoreceptor cells [NX]	Single Cell Type RNA - Sertoli cells [NX]	Single Cell Type RNA - Smooth muscle cells [NX]	Single Cell Type RNA - Spermatocytes [NX]	Single Cell Type RNA - Spermatogonia [NX]	Single Cell Type RNA - Suprabasal keratinocytes [NX]	Single Cell Type RNA - Syncytiotrophoblasts [NX]	Single Cell Type RNA - T-cells [NX]	Single Cell Type RNA - Undifferentiated cells [NX]	Single Cell Type RNA - Urothelial cells [NX]	RNAsingleCellTypeSpecific
FSTL3	FLRG, FSRP	ENSG00000070404	Follistatin like 3	O95633	19	676365-683399	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins	Osteogenesis, Transcription, Transcription regulation		Cancer-related genes, Proto-oncogene	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	6	placenta: 201.0	Cell type enriched	Detected in many	4	Extravillous trophoblasts: 2939.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		BEWO: 36.2;hTCEpi: 40.0;SiHa: 73.8;U-2197: 38.1	Not detected	Not detected			Low region specificity	Detected in all			CAB024899, HPA045378	Approved		Supported	Nucleoplasm	Secreted in other tissues		Yes		6800000	Nucleoplasm		CAB024899: , HPA045378: AB_2679300	unprognostic (9.86e-3)	unprognostic (1.32e-3)	prognostic unfavorable (3.01e-4)	prognostic unfavorable (3.03e-4)	unprognostic (2.19e-3)	unprognostic (1.51e-3)	unprognostic (8.64e-3)	prognostic unfavorable (4.61e-7)	unprognostic (9.50e-2)	prognostic unfavorable (1.65e-4)	unprognostic (3.50e-2)	unprognostic (5.91e-2)	unprognostic (1.03e-3)	unprognostic (7.22e-3)	unprognostic (3.07e-1)	unprognostic (3.75e-1)	unprognostic (5.89e-3)	19.9	29.1	4	10.7	6.2	5.6	24.7	1.3	4.2	13.1	14.9	3.8	8.1	3.8	12.8	15.6	12.7	14.1	13.1	27	5	2	13.7	5.1	26.9	8.7	7.3	4.5	16.8	11.7	1.4	5.3	201	6	14.3	3.1	12	4.5	11	4.1	6.2	6.5	20.6	10.4	3.9	9.1	34.5	4.9	0.7	7.2	5.5	1.4	16.7	18.3	0.9	2.2	0.1	4.4	0.6	2.6	2	1.9	15.9	1.1	0.8	5	12.8	36.2	27	4	6.8	2.5	5.8	3.1	0.8	10.9	18.2	3.9	13.9	0.9	23	2.2	1.6	1.9	0.7	22.2	4.7	21.6	1.4	2.6	16	40	7.5	31.3	17.6	1.2	0.8	1.7	1.1	10.2	7	0.5	0.8	1.3	13.1	5.5	1.5	0.7	1.8	9.4	0.3	0.7	1.2	73.8	1.5	0.8	1.4	1.3	0.7	16.2	6.8	23.5	38.1	9.9	1.8	0.8	0.4	1	4.2	3.1	0	4.4	0	1	4.4	0.2	0.3	1.4	1.1	2.2	0.9	2.6	1.6	0.1	0.6	3.2	0.9	0.2	2	4	6.2	1.3	4.2	5	2	7.3	4.5	6	4.9	17.9	3.4	2.2	19.6	12.9	1.6	12.8	30.6	2.7	1.2	8.7	0	22.7	6.6	69.7	5.6	4.5	0.9	0	56	2939.6	52.2	21.7	0	0.9	68.4	3.2	1.2	22.1	3.8	6.5	56.7	4	5	11.8	0.9	7.8	198.1	0	25.1	5.6	0.5	45.3	32.5	2.3	7.7	6.8	662.4	2.9	1.7	20.7	Extravillous trophoblasts
ANKRD24	KIAA1981	ENSG00000089847	Ankyrin repeat domain 24	Q8TF21	19	4183354-4224814	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 22.1	Cell type enriched	Detected in some	4	Extravillous trophoblasts: 17.7	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enriched	Detected in single	9	memory B-cell: 1.3	Lineage enriched	Detected in single	9	B-cells: 1.3	Cell line enhanced	Detected in some		Karpas-707: 5.6;U-266/70: 18.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA041534, HPA048498	Uncertain		Uncertain	Microtubules,Cytosol						Microtubules, Cytosol		HPA041534: AB_2677537, HPA048498: AB_2680420	unprognostic (3.70e-2)	unprognostic (3.96e-3)	unprognostic (5.23e-9)	unprognostic (7.03e-2)	unprognostic (5.01e-2)	unprognostic (2.31e-1)	prognostic favorable (9.13e-5)	unprognostic (1.53e-1)	unprognostic (3.52e-2)	unprognostic (3.41e-2)	unprognostic (1.19e-3)	unprognostic (2.63e-2)	unprognostic (1.27e-2)	unprognostic (7.63e-2)	unprognostic (1.61e-1)	unprognostic (2.43e-2)	unprognostic (1.73e-4)	1.4	2.1	6	0.8	8.5	1.1	1.2	1.4	22.1	1	1.1	0.8	0.1	1.9	1	2.1	0.5	1.4	1.3	0.6	5.1	4.4	1.8	5.5	1.1	1	4.1	9.4	1.4	3.3	2.4	3.8	1.9	2.3	4.3	0.9	1	1.7	1.7	2.5	1.1	1.5	0.7	2.3	1.5	1.6	7.3	1.8	0.1	1.9	0.1	0.6	0.6	0.1	1.3	0	0	0	0	0.1	0	0.1	0.2	0	0.1	3.2	0.3	3.4	0.2	0.1	0	0	0.1	0.1	0.1	2	0.4	0.2	0.2	0.1	0.5	0	2.4	0.3	0.1	0.1	0.1	1.8	0.1	0.3	1.8	0.1	0.3	0.8	0.5	0.1	2	0.1	5.6	0	0.7	0	0.1	2.5	0.7	0.7	0.4	0	0.4	0	0.2	0.9	0.2	0.1	0.1	0.3	0.6	0.7	0.4	0	0.1	1.2	0.9	0	18.9	1.6	0.1	0.8	0.7	0.1	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0.1	0	6	8.5	1.4	22.1	5.1	4.4	4.1	9.4	2.3	1.8	0	3.4	0	0.2	0	0.8	0.8	2.5	0	2.3	0	3.9	0.2	0	0.1	0.5	0	0.3	0	0	17.7	0	0.2	0	1	0.3	0	3.5	0	0.6	0.9	0	0	0	0	0.3	0.8	0	0	0	0.8	1.1	0	0	0.7	1.1	0	0.9	0	0.2	0	Extravillous trophoblasts
CCNE1	CCNE	ENSG00000105173	Cyclin E1	P24864	19	29811898-29824308	Cancer-related genes, Predicted intracellular proteins	Cell cycle, Cell division	Cyclin	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		bone marrow: 23.3;placenta: 46.7	Cell type enriched	Detected in many	14	Extravillous trophoblasts: 1526.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		BEWO: 81.6	Low region specificity	Detected in all							CAB000308, CAB016682, HPA018169	Approved		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384	unprognostic (2.90e-3)	unprognostic (1.33e-2)	unprognostic (1.47e-3)	prognostic unfavorable (6.35e-6)	unprognostic (5.78e-2)	unprognostic (4.77e-2)	prognostic unfavorable (3.89e-5)	unprognostic (1.26e-3)	unprognostic (3.14e-3)	prognostic unfavorable (2.97e-4)	unprognostic (3.29e-2)	unprognostic (7.07e-2)	unprognostic (1.11e-16)	unprognostic (5.61e-2)	unprognostic (1.92e-1)	unprognostic (6.63e-2)	unprognostic (1.46e-1)	1.6	6.8	2.4	4.5	2.9	23.3	0.6	6.3	3.3	0.8	3	1.7	1.1	2.3	1.2	0.6	4.7	0.7	2.2	4.4	2.3	2.8	1.2	0.7	1.1	4.6	1.9	1.9	0.9	1.4	1.7	1	46.7	2.8	1.1	3.8	1.5	3.2	1.2	2.2	4.4	2.5	3	1.7	4.6	2	12.3	1.6	4.1	1.6	2.1	5.9	2.7	2.5	2.7	1.6	1.6	1.9	0	1.4	0.5	4.1	8.6	6.6	9.4	1.4	1.6	81.6	6.6	1.4	2.9	3.6	8.7	8.4	3.5	15.7	2.9	3.8	1.3	7.8	3.4	4.2	11.1	4.8	2.9	8.4	9.1	1.1	11.5	7.9	1.7	1.9	4	0.5	0.9	3.5	3.5	11.8	1.6	4.4	6.2	6.3	3.3	11	9.4	2	9.5	7.7	2.6	2.2	6.6	5.6	4.7	9.5	11.7	1	10.1	2.6	8.6	2	6.9	25.9	4.1	4.4	6.6	4.6	23.9	3.9	1.4	3.7	0	0.1	0	0.6	1.9	1.1	2.7	0.5	0.4	1.6	0.2	0.1	0.9	1.6	0	1.9	0	1.4	0.5	2.4	2.9	6.3	3.3	2.3	2.8	1.9	1.9	2.8	1.6	0	1.1	0.8	1	4.2	2.4	2.8	0	0	2.3	0	0	112.5	0	0.4	7.1	1.1	1.7	0	0.6	1526.8	4.8	1.9	0	0	37.5	3.2	2.9	1.3	0.3	2.6	1.1	1.1	1.7	0	2.7	1.8	1	2.9	2.1	0.2	0.8	6.5	3.1	14.1	19.5	5.3	96.8	2.2	3.8	2.4	Extravillous trophoblasts
DLX4	BP1, DLX7, DLX8, DLX9	ENSG00000108813	Distal-less homeobox 4	Q92988	17	49968970-49974959	Disease related genes, Predicted intracellular proteins, Transcription factors		Developmental protein, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		placenta: 14.7;skin 1: 6.0	Cell type enriched	Detected in some	5	Extravillous trophoblasts: 67.1	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		BEWO: 18.6;CACO-2: 13.1;GAMG: 12.4;HAP1: 9.0;K-562: 10.3	Low region specificity	Detected in some			Not detected	Not detected			HPA059933	Uncertain		Supported	Nucleoplasm						Nucleoplasm		HPA059933: AB_2684169	unprognostic (8.12e-2)	unprognostic (2.48e-1)	unprognostic (1.26e-2)	unprognostic (2.29e-3)	unprognostic (7.49e-2)	unprognostic (2.71e-1)	unprognostic (9.35e-3)	unprognostic (2.85e-2)	unprognostic (8.73e-2)	unprognostic (5.93e-2)	unprognostic (1.29e-2)	unprognostic (4.34e-2)	unprognostic (2.88e-13)	unprognostic (8.79e-3)	unprognostic (2.77e-1)	unprognostic (5.00e-2)	unprognostic (6.86e-2)	0.4	0.3	0.2	1.2	0.7	0.4	0.7	0.3	0.8	0.8	0.6	0.8	0.2	0.2	0.2	0.6	1.5	0.5	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.5	0.2	0.2	0.2	0.7	0.1	0.2	14.7	1.4	0.5	0.3	0.5	2.7	0.6	0.2	6	1.5	0.2	0.2	0.8	0.3	0.5	0.2	0.2	0.6	3.8	1.2	0.4	0.8	0.1	0.9	0	1.3	1	0.8	0.3	0.4	1.1	0	0.1	0.1	0	18.6	0.1	0.1	0	0.3	13.1	0.8	0.5	2.7	0.2	12.4	1.8	9	0.3	0	3.5	4.7	0.3	4.5	1.3	0	0.7	3.1	0	2.3	0.1	0	0.1	0	2.7	10.3	0	0	2.2	0.3	4.7	0.2	2.4	0	0	4.2	0.4	0.1	0.6	1.5	0	0.3	1.6	0.8	2.9	3.3	3.1	0	0	0.9	0.2	0	0.7	0.1	0	0.3	2.4	0	0	0.3	0	0.8	1.3	0	0	0	0.4	0.7	0.1	0.2	0	0	1	1.3	0.9	0	0.3	0.2	0.7	0.3	0.8	0.2	0.2	0.2	0.2	1.4	0.2	6	0	0	0.3	2.3	0	2	0	2.7	0	0	0	10.5	0	0.1	0	0	0	0	0.2	67.1	0.2	0	0	0	1.8	0	0	0	0.3	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.7	0.7	0.5	14.1	0	0	0.3	Extravillous trophoblasts
KISS1R	AXOR12, GPR54, HOT7T175	ENSG00000116014	KISS1 receptor	Q969F8	19	917287-921015	Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters		G-protein coupled receptor, Receptor, Transducer	Disease mutation, Hypogonadotropic hypogonadism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 6.8;lymphoid tissue: 12.4	Cell type enriched	Detected in some	18	Extravillous trophoblasts: 31.2	Cancer enhanced	Detected in many		renal cancer: 3.6	Low region specificity	Detected in many			Cell type enhanced	Detected in some		naive CD4 T-cell: 2.0;neutrophil: 1.8	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		K-562: 10.8;RPMI-8226: 26.3;SCLC-21H: 5.5;SH-SY5Y: 14.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA007156, HPA071913	Approved		Supported	Vesicles,Plasma membrane						Plasma membrane	Vesicles	HPA007156: , HPA071913: AB_2686471	unprognostic (1.54e-1)	unprognostic (3.01e-2)	unprognostic (9.42e-2)	unprognostic (2.15e-1)	unprognostic (8.46e-3)	unprognostic (9.23e-2)	unprognostic (1.65e-2)	unprognostic (3.23e-1)	unprognostic (1.37e-1)	unprognostic (1.16e-1)	unprognostic (1.48e-2)	unprognostic (7.17e-2)	prognostic unfavorable (3.33e-6)	unprognostic (1.87e-1)	unprognostic (8.09e-3)	unprognostic (1.05e-1)	unprognostic (2.05e-2)	0.2	0.2	2.1	2.1	4.1	0.2	0.3	0.1	4.7	0.1	0.3	0.1	0.1	0.4	0.2	0.1	0.1	0.2	0.1	0.1	1	6.8	1.4	0.1	0.3	12.4	1.1	0.1	0.4	3.6	0.1	2	1	0.8	0.2	0.2	0.3	0.3	0.1	0.1	0.1	0.7	0.5	1	2.4	0.4	0.1	0.1	0.1	0.1	0.1	0.6	0.5	0.1	0.6	0	1.8	0	0	2	0	0	0.5	0.1	0	0	0	0.1	0	0	0	0	1.7	0	0	0.1	0	0	0	0.8	0	0	0.2	2.9	0	0	3.3	0	0	0	0	0	0	0	0	0	0.1	10.8	0	0	0.2	0.1	0	0.4	0.8	0.3	0.7	0	26.3	0	0	5.5	14.7	0	0	0	0	0.2	0.6	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.6	0.7	0	0	0.1	2	0.6	1.8	0	0	0	0.1	0	2.1	4.1	0.1	1.5	1	6.8	1.1	0.1	0.8	0.1	0	0	1.4	0.1	0.1	0.7	0.4	0	0	0	0	0	0.3	0	0.7	0	0	0	0	0.2	31.2	0	0.3	0	0	0.7	0	0	0	0	0	0	0	1.7	0	0	0.1	0.1	0	0	0	1.6	0	0	0	0.4	0.3	1.4	0	0	0	Extravillous trophoblasts
QSOX1	QSCN6	ENSG00000116260	Quiescin sulfhydryl oxidase 1	O00391	1	180154834-180204030	Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins		Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		placenta: 172.2	Cell type enriched	Detected in many	8	Extravillous trophoblasts: 1528.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		HHSteC: 197.7	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA056243			Supported	Golgi apparatus,Vesicles	Secreted to extracellular matrix				3200000000	Golgi apparatus	Vesicles	HPA056243: AB_2683077	unprognostic (1.13e-1)	unprognostic (2.62e-3)	unprognostic (2.46e-1)	unprognostic (2.49e-2)	unprognostic (2.00e-2)	unprognostic (2.73e-1)	unprognostic (5.47e-2)	unprognostic (2.22e-1)	unprognostic (3.94e-1)	unprognostic (3.12e-2)	unprognostic (5.07e-2)	unprognostic (2.80e-3)	prognostic unfavorable (1.86e-5)	unprognostic (3.25e-1)	unprognostic (2.14e-1)	unprognostic (3.53e-2)	unprognostic (1.40e-1)	15.9	18.7	8	14.5	9.5	30.1	12.6	7.3	13.6	23.5	25.3	13.8	24.9	19.8	17.8	44.9	36.8	18.9	91.9	54.4	10.1	9	15.4	23.1	42.3	19.5	8.5	9.1	46.5	59.8	6.2	13.5	172.2	13.4	28	24.5	12.1	20.6	19.4	18.4	12.3	19	33.9	15.5	13.4	52.8	50.3	9.1	6.7	7.8	18.2	18.3	35.8	26.1	2.9	19.2	20.4	25.5	8	7.1	11.4	42.1	6	1.4	18	18.4	38.1	71.7	44.9	45.4	38.4	27.1	0.7	13.6	0.6	27.9	35.9	5.3	9.2	1.7	12.1	18.8	2.5	2.7	1.3	3.5	1.8	197.7	4.6	13	20.3	5.5	40.9	49.1	50.6	56.5	3.1	1.9	6.6	25.2	7.3	0.9	8.6	4.9	29.2	17.3	1.8	3.3	1.1	6.3	12	5.2	5.3	13.1	17.9	8.7	3.4	3.2	21.9	66.5	48.1	18.9	32.2	37.9	4.8	7.9	1.1	18.3	14.8	14.4	5.8	25.5	9.5	7.1	14.7	5.3	2.9	4.8	5	19.2	1.8	4.4	4.3	20.4	8	13.1	3.9	5.5	11.4	8	9.5	7.3	13.6	10.1	9	8.5	9.1	13.4	9.1	53.6	87.2	7.8	26.2	12.2	9.8	43.7	68.8	14.7	43.3	68	23.6	13.2	0	189.3	48.3	38.6	47.7	0	114.6	1528.4	54.2	30.1	25.3	1.5	63.8	6.4	44.4	101.9	45.4	16.5	164.5	43.6	42.2	44.1	163.8	43.9	172.2	143.8	66.8	9.5	6.5	32.3	17.5	20.9	25.4	8.7	129.1	15	96.4	58	Extravillous trophoblasts
C1QTNF6	CTRP6, ZACRP6	ENSG00000133466	C1q and TNF related 6	Q9BXI9	22	37180167-37199385	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	endometrium 1: 23.7;placenta: 79.5	Cell type enriched	Detected in many	12	Extravillous trophoblasts: 349.8	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		MCF7: 45.0;RT4: 20.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA002042	Enhanced		Approved	Nucleoplasm	Secreted to blood	No	No	354000000		Nucleoplasm		HPA002042: AB_1078342	unprognostic (9.65e-2)	unprognostic (1.21e-2)	unprognostic (2.32e-1)	unprognostic (2.23e-3)	unprognostic (1.25e-3)	unprognostic (3.01e-2)	unprognostic (3.17e-2)	prognostic unfavorable (9.60e-6)	unprognostic (6.96e-2)	unprognostic (5.11e-2)	unprognostic (2.61e-2)	unprognostic (1.72e-1)	prognostic unfavorable (0.00e+0)	unprognostic (1.61e-2)	unprognostic (5.36e-2)	unprognostic (1.08e-3)	unprognostic (1.52e-2)	3.3	4.4	1.2	4.2	1.6	0.8	2.5	1.2	1.8	7.8	2.5	1.3	1.6	1	23.7	7.2	1.6	5.2	6.2	3.1	1.4	0.7	3.9	7.9	9.2	3.1	1.2	1.3	5.9	2.3	1.4	1.4	79.5	1.7	4.3	2.5	4.4	2.2	3.4	1.5	3.1	3.2	5.7	1.8	4.6	1.8	3.5	1.2	1.6	2.4	1.7	1.8	5.1	2.7	2.4	1.1	1.8	0.5	4	3.8	1	6.7	8.4	4.4	1.5	0.8	8.9	13.4	1.4	2.8	1.1	0.8	1.5	9.9	0	5.7	2.3	0.6	14	0.1	3.4	0.5	1.9	1.1	1.1	3.2	1.5	3.1	0	0.9	12.3	1.9	0.9	0.2	3	10.6	0.3	0	3.1	0.4	45	0	0.2	2.8	1	0.1	0.1	0	1.1	10.2	20.8	0.7	5.7	0.4	8.1	1.1	2.4	2.8	0.2	3.6	0.4	2.3	0.1	0	6.5	0.1	0	0.9	0.8	1.2	1	0.5	1.5	0.7	0.5	0.8	0.8	1.3	1	0.5	2.4	2.9	2.2	1.8	4	0.3	1.1	3.8	1	1.2	1.6	1.2	1.8	1.4	0.7	1.2	1.3	1.7	1.2	0	0	3	1.4	1.3	0.9	1.1	2.5	4	2.3	1.8	0	4.2	1.7	1.9	1.7	1.4	2.6	0	1	349.8	8.9	0.6	1.1	5	8.4	0	0	11.6	1	6.2	0.6	0.9	5	1	2.1	4.2	2	3.5	0.4	1.3	0.7	0	3.3	7	4	0.3	28.8	2.5	3.9	1	Extravillous trophoblasts
CCNB1	CCNB	ENSG00000134057	Cyclin B1	P14635	5	69167010-69178245	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters	Cell cycle, Cell division, Mitosis	Cyclin	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		lymphoid tissue: 71.4	Cell type enriched	Detected in many	9	Extravillous trophoblasts: 610.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many			Low region specificity	Detected in single			Low region specificity	Detected in all			CAB000115, CAB003804, HPA030741, HPA061448	Enhanced		Enhanced	Cytosol		Yes	Yes			Cytosol		CAB000115: , CAB003804: AB_562272, HPA030741: AB_2673586, HPA061448: AB_2684522	unprognostic (4.12e-2)	unprognostic (2.75e-2)	unprognostic (1.91e-3)	unprognostic (4.08e-3)	unprognostic (2.78e-1)	unprognostic (1.39e-1)	prognostic unfavorable (1.54e-7)	prognostic unfavorable (3.38e-4)	unprognostic (1.43e-2)	unprognostic (1.63e-2)	unprognostic (2.49e-3)	unprognostic (1.40e-1)	prognostic unfavorable (1.11e-16)	unprognostic (2.44e-1)	unprognostic (3.73e-1)	unprognostic (1.44e-1)	unprognostic (5.15e-3)	3.2	4.6	2.7	23.9	4.8	20.5	4.6	6.5	5.6	4.4	9.9	1.6	1.6	9.3	3.5	2.8	28.8	3.3	3.5	1.9	3.5	4.2	4.6	2.9	3.4	23.6	4	4.2	3.7	4	1.6	2.6	12.1	11.5	2.6	14.2	1.7	5.3	1.7	2	6.4	8.7	6.4	2.5	9.1	7.1	21.7	1.3	71.4	6.3	23.3	30.1	5.3	7.5	13.2	5.1	2.4	4.1	6.5	14.7	5.5	58.6	40.6	55.8	49.6	2.9	5	131.7	26	19.5	68.6	58.1	60	55.4	36.1	31.7	23.9	78.7	37	56.1	56.8	77	35.4	27.7	22.9	33.9	41.4	0.9	19.9	26.2	2.2	3.6	39.3	27.4	6.3	36.6	35.4	27.6	28.7	55.8	55.9	27.2	23.7	31	19.5	25.8	28.7	40.2	37	25.1	21.7	28.4	17.9	44.7	21.1	19.2	32.8	40.3	20.9	15.3	15.3	49.7	27.6	64.9	14.4	26.6	50.4	21.2	34.9	47	2.4	1.8	1.2	2.8	4.1	4	13.2	7.6	6.7	5.1	8.6	2.5	2.4	1	6.5	1.9	4.2	14.7	5.5	2.7	4.8	6.5	5.6	3.5	4.2	4	4.2	11.5	1.3	0	0.3	5.2	4.8	10.2	4.2	1.5	2.5	13.4	4.5	5.2	2	53.5	1.7	5.3	63.8	1.8	2.9	46.7	1.2	610.8	11.3	3.6	2.3	3	50.4	0	1.2	6.2	6	9.4	2.8	4.4	3.3	3.6	4.6	2.8	2.5	0	2.5	4.3	2.9	6.5	3.1	28.8	70.2	6.4	34.7	4.4	11.5	2.7	Extravillous trophoblasts
MYCN	bHLHe37, MYCNOT, N-myc, NMYC	ENSG00000134323	MYCN proto-oncogene, bHLH transcription factor	P04198	2	15940564-15947007	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding	Cancer-related genes, Disease mutation, Proto-oncogene	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		placenta: 16.8	Cell type enriched	Detected in some	8	Extravillous trophoblasts: 75.4	Cancer enhanced	Detected in many		testis cancer: 45.5	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 12.9;BEWO: 70.2;HMC-1: 16.9;NTERA-2: 26.6;RH-30: 18.6;SuSa: 12.6	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA057420			Approved	Nucleoplasm,Nucleoli						Nucleoli	Nucleoplasm	HPA057420: AB_2683434	unprognostic (8.04e-2)	unprognostic (1.96e-1)	unprognostic (1.29e-1)	unprognostic (2.07e-2)	unprognostic (4.11e-1)	unprognostic (2.46e-2)	unprognostic (1.23e-2)	unprognostic (3.03e-2)	unprognostic (1.81e-1)	unprognostic (3.35e-3)	unprognostic (3.09e-2)	unprognostic (2.09e-1)	unprognostic (1.12e-3)	unprognostic (8.89e-2)	unprognostic (2.47e-1)	unprognostic (4.90e-2)	unprognostic (1.23e-1)	0.9	1.9	5.1	1.8	5.5	1.6	1.2	1.4	8.4	3.1	1.2	12.1	0	3	1.9	0.8	1.3	1.4	2.6	2.3	7	4.7	6	1.5	1.6	2.9	6	2.2	10.3	0.7	0.4	0.7	16.8	6.8	0.6	1.3	1.1	6.6	0.7	1	2.4	1.7	0.9	8.9	0.9	8.5	6.5	4	5.7	5.1	2.3	3.5	2	0.9	0	0	0	0	0	0	0	0	0	12.9	0	0	0	70.2	0	0	0	0	1	0	0	1.2	0	0	0	0.5	0	0	0	0	4.7	0	0	0	0	16.9	0	0	0	0	0	0	0.2	0	0	0	0.2	0.1	0	26.6	0.6	0	0	18.6	3.5	0	0.9	0.2	4.7	0	0	0	12.6	0	0	0	0	0.3	0	0	0.8	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.1	5.5	1.4	7	7	4.7	6	2.2	6.8	4	0	0	0	0.1	0.5	2.6	0.7	0	0	0	0	0	4.4	0	0	1.2	0.2	0	0	0	75.4	0.6	0	0	0.5	2	0	0	0	0	0	0	0	0	0	0.7	0.8	0.2	0	0.4	2.1	0.1	0	0	0.5	3.6	0	9.6	0	0.2	0	Extravillous trophoblasts
HAPLN3	EXLD1, HsT19883	ENSG00000140511	Hyaluronan and proteoglycan link protein 3	Q96S86	15	88877288-88895626	Predicted membrane proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 25.4;lymphoid tissue: 23.6	Cell type enriched	Detected in many	8	Extravillous trophoblasts: 899.6	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in many		T-reg: 25.4	Lineage enriched	Detected in many	5	T-cells: 25.4	Cell line enhanced	Detected in many		HDLM-2: 21.0;U-2 OS: 21.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA039237	Approved		Approved	Plasma membrane,Cytosol	Secreted to extracellular matrix					Plasma membrane, Cytosol		HPA039237: AB_10805357	unprognostic (1.67e-2)	unprognostic (1.04e-3)	unprognostic (2.57e-1)	unprognostic (2.53e-2)	unprognostic (3.27e-1)	unprognostic (2.24e-2)	unprognostic (4.21e-1)	unprognostic (3.82e-1)	unprognostic (3.37e-3)	unprognostic (7.37e-3)	unprognostic (1.13e-3)	unprognostic (4.30e-1)	prognostic unfavorable (4.18e-13)	unprognostic (1.95e-1)	unprognostic (3.01e-2)	unprognostic (6.12e-2)	unprognostic (1.12e-1)	9.9	1.3	1.1	20.6	2.7	4.4	8.7	1	2.3	5.3	2.6	1.1	0.3	1.4	4.4	4.9	5.7	6	4.7	9.8	3.2	1	3	0.8	8.7	23.6	3.1	0.9	5.2	2.3	0.9	2.2	2.7	3.6	5.2	1.1	3.2	6.4	1.6	4.2	6	4.1	4.7	6.2	6.9	3.6	1.9	1.8	5.7	7.2	7.6	10.9	6	5.6	0.8	1.1	0.7	0.6	4.8	25.4	3.2	1.2	4.4	0.9	9.8	2.8	3	3.1	2.7	0.6	1	1.3	2.8	4.1	0	7.8	3.4	1.6	1	9.3	1.2	0	21	8.2	3	0.2	0	0.4	0	0.1	1.1	0.5	2	0.1	0.1	4.6	0.4	0	6	0.4	0.1	0	0	7.3	0	0.1	0	0.4	7.3	1.8	0.1	0.1	2.7	0.5	0.5	3.7	1.2	0	0.4	0.8	7.1	21	5.3	0.4	0.9	0	0	2.5	0	6.1	0.7	0.6	0	0.6	0.3	3	0.1	10	4.1	1.1	0.8	10.2	4.5	0.1	4.8	0.1	0.4	25.4	3.2	1.1	2.7	1	2.3	3.2	1	3.1	0.9	3.6	1.8	0	4.3	0.9	6	28.4	2.6	7.7	0	1.4	5.7	1.8	9.8	5.6	0	5.7	0	18.6	0	0	1.8	899.6	9.3	3.9	1.1	0	17.6	0	0	3.1	0	0	0.9	2.9	16.9	16.2	0.2	2.4	8.7	0	0.7	0.1	108.4	12.9	38.9	0.5	1.7	21.1	17	3.2	0.2	6.8	Extravillous trophoblasts
N4BP3	LZTS4	ENSG00000145911	NEDD4 binding protein 3	O15049	5	178113443-178126087	Predicted intracellular proteins	Neurogenesis	Developmental protein		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		placenta: 31.5	Cell type enriched	Detected in many	4	Extravillous trophoblasts: 120.1	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in some	4	memory B-cell: 4.0;naive B-cell: 4.0;naive CD8 T-cell: 2.6;plasmacytoid DC: 4.4	Group enriched	Detected in many	18	B-cells: 4.0;dendritic cells: 4.4;T-cells: 2.6	Cell line enhanced	Detected in many		BEWO: 8.0;MCF7: 10.9;RH-30: 10.9;SK-BR-3: 38.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA030972, HPA030973, HPA061387	Approved		Supported	Nucleoplasm,Centrosome						Nucleoplasm	Centrosome	HPA030972: AB_2673680, HPA030973: AB_10603574, HPA061387: 	unprognostic (1.84e-1)	unprognostic (1.70e-2)	unprognostic (4.96e-3)	unprognostic (6.64e-3)	unprognostic (2.06e-1)	unprognostic (3.18e-3)	unprognostic (1.88e-6)	unprognostic (1.45e-1)	unprognostic (1.61e-1)	unprognostic (1.92e-2)	unprognostic (3.28e-3)	unprognostic (9.55e-2)	prognostic favorable (2.38e-4)	unprognostic (2.62e-1)	unprognostic (1.16e-1)	unprognostic (1.22e-1)	unprognostic (1.06e-1)	6.6	1.3	1.9	2.6	2.1	3.5	13.9	6.5	4.3	2.5	1.8	0.7	0.5	0.8	1.1	0.6	16.2	1.5	1.3	3.2	1.8	2.6	2.5	0.2	8.4	4	2.1	1.2	1.4	1.1	10.1	2.5	31.5	3.1	2	0.6	1.5	9.5	1.3	5.7	7.8	1.9	1.3	1.2	5.9	3.1	1.4	1.3	0.4	2	4.7	11.2	4.9	3.8	4	4.4	0	0	0.2	2.6	0.5	0	0	1.2	0.9	0.1	0	8	0	0	0	0	1.7	0.6	0.7	1.1	0	0.1	2.5	0.2	0	0	1.2	0.4	2.1	0.8	0	0	0.1	0	0.1	0.2	0	0	0	6.4	0.7	1.3	0.5	0	10.9	0.1	0.1	6	1.8	0	6	10.9	2.7	0.6	1.2	0.9	0.4	0.3	38.8	2.5	1.6	1.4	0	1.2	0	0.9	0	0	1.7	1.2	6.8	0	0	0.4	0	0	0	0.4	0	0.3	4	0.2	0.2	0	4	0.9	2.6	0	0.2	0	4.4	0	0.5	1.9	2.1	6.5	4.3	1.8	2.6	2.1	1.2	3.1	1.3	3	1.1	5.9	11.5	8.4	27.3	1.5	2.5	0	0	1.8	11.8	1.7	11.6	3.4	0.1	4	2.6	0	0.7	120.1	0.9	9.9	4.6	0	2	1.6	4.1	0	0	0.4	0.6	1.1	11.8	1.8	1.8	1.9	4.7	5.3	1.8	0.3	8.9	0	0.9	0.1	6.9	5.9	19.3	1	1.9	10.6	Extravillous trophoblasts
GPR78		ENSG00000155269	G protein-coupled receptor 78	Q96P69	4	8558725-8619761	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	13	placenta: 53.3	Cell type enriched	Detected in some	5	Extravillous trophoblasts: 4.8	Cancer enhanced	Detected in single		urothelial cancer: 1.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	202	BEWO: 21.7									HPA013209	Uncertain											HPA013209: AB_10601657	unprognostic (6.41e-2)	unprognostic (1.77e-2)	unprognostic (1.17e-2)	unprognostic (2.51e-1)	unprognostic (1.81e-2)	unprognostic (3.70e-2)		unprognostic (3.82e-4)	unprognostic (6.46e-3)	unprognostic (1.20e-1)	unprognostic (3.80e-2)	unprognostic (2.29e-1)	unprognostic (4.88e-15)	unprognostic (5.55e-3)	unprognostic (3.93e-2)	unprognostic (9.90e-3)	unprognostic (8.15e-2)	0	0	0	0.1	0.1	0	0	0.2	0.5	0.1	0	0	0	0	0	0	3.9	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	53.3	0	0	0	0	0.2	0	0	0.2	0	0	0	0	0	0	0	0.2	0	0	0	0.3	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	21.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0.5	0.1	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0.2	0	0	0	0	0	0	0	4.8	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	Extravillous trophoblasts
ACAN	AGC1, CSPG1, CSPGCP, MSK16	ENSG00000157766	Aggrecan		15	88803442-88875354	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level				Low tissue specificity	Detected in many			Cell type enriched	Detected in some	28	Extravillous trophoblasts: 120.0	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in single		basophil: 1.5	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	5	WM-115: 22.9	Low region specificity	Detected in many			Not detected	Not detected			CAB016377, HPA038241, HPA038242	Enhanced				Secreted to extracellular matrix							CAB016377: AB_626650, HPA038241: AB_2675909, HPA038242: AB_2675910	unprognostic (2.69e-3)	unprognostic (4.09e-2)	unprognostic (2.52e-1)	unprognostic (1.82e-1)	unprognostic (4.43e-2)	unprognostic (2.13e-2)	unprognostic (1.40e-2)	unprognostic (1.15e-1)	unprognostic (7.12e-2)	unprognostic (8.57e-2)	unprognostic (2.34e-1)	unprognostic (2.38e-2)	prognostic unfavorable (1.47e-6)	unprognostic (7.79e-2)	unprognostic (1.53e-1)	unprognostic (7.71e-2)	unprognostic (7.27e-2)	5	1.2	2.7	3.2	4.6	0.8	0.9	0.6	6.6	9.2	1.6	3.4	0.1	0.9	5.3	3.9	1	1.4	3	6.5	2	6.2	6.3	0.8	4.2	0.8	2.5	0.9	2.2	1.2	0.6	2.1	1.9	3.7	2.4	1.7	1.1	1.1	11.2	1.8	1.5	0.8	2.1	5.7	1.3	1.2	4.9	2.3	0	1.9	1.8	0.6	5.9	4.4	0.2	0.3	1.5	0.4	0.5	0.3	0.1	0	0	0	0	0.9	0	4.7	0.3	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0.2	3.5	0	0	0	0	0	0	0	22.9	1.5	0.2	0.2	0.3	0.4	0.2	0	0.1	0.2	0.1	0.2	0.2	0.2	0.6	0.5	0.1	0.3	0.2	0.1	2.7	4.6	0.6	6.6	2	6.2	2.5	0.9	3.7	2.3	0	0	0	0.4	0.3	0	1.9	0	0	0	0	0	0.5	0	0	0	0.4	0	0	0	120	0.8	0.2	1.1	0	2.3	0	0	0	0	1.9	0	0.1	1.7	0	0	0	0	0	0	0	0	0	4.3	0.3	2.8	0.4	3	0	0	0.3	Extravillous trophoblasts
ITGA5	CD49e, FNRA	ENSG00000161638	Integrin subunit alpha 5	P08648	12	54395261-54419460	Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins	Cell adhesion, Host-virus interaction	Host cell receptor for virus entry, Integrin, Receptor	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		smooth muscle: 137.7	Cell type enriched	Detected in many	4	Extravillous trophoblasts: 377.0	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in many		neutrophil: 31.5	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		hTERT-RPE1: 67.2;HUVEC TERT2: 141.7;TIME: 134.9;U-87 MG: 67.3	Region enriched	Detected in single	7	basal ganglia: 9.3	Not detected	Not detected			HPA002642, CAB009008	Enhanced								23000000			CAB009008: AB_647474, HPA002642: AB_1078469	unprognostic (7.51e-3)	prognostic unfavorable (4.07e-6)	prognostic unfavorable (8.43e-4)	unprognostic (1.58e-1)	unprognostic (8.51e-3)	prognostic unfavorable (2.91e-4)	prognostic unfavorable (2.23e-5)	prognostic unfavorable (2.44e-4)	unprognostic (2.76e-2)	unprognostic (6.19e-2)	unprognostic (8.99e-2)	unprognostic (8.28e-2)	prognostic unfavorable (1.32e-8)	unprognostic (2.11e-3)	unprognostic (3.35e-2)	prognostic unfavorable (8.89e-4)	unprognostic (2.18e-3)	23.3	7.9	2.1	32.2	2.8	9.2	30.5	1.2	2.2	16	66.9	2.2	19	3.4	19.3	13.8	18.2	12	12.4	20.3	2.9	0.8	4.6	15.2	20.4	9.2	3.2	1.2	13.6	5.3	3.7	1.8	57.7	3.3	26.6	10.2	4.9	4.4	28.9	10	8.8	14.9	137.7	3.5	3.1	19.7	6.6	2.5	3	7.3	5.8	4.5	82.1	20.6	0.1	22.2	31.5	22.9	9.1	5.6	12.4	6.6	2.4	4.6	0	14.4	30.6	12.1	30.2	31.4	31.1	23	1.7	1.5	0	22	31.5	15.7	1	1.2	8.4	21.6	0	1.2	2.9	3.4	0.1	19.9	9	4.6	22.1	4.2	36.5	28	67.2	141.7	1.5	2.4	0	17.6	0.6	1.4	10.1	1.9	0.4	2	1.4	3.1	0.6	4.9	0.1	0	0	6	0.4	0.2	10.6	0.7	8.2	134.9	37.9	6.7	9.2	12.5	0	0.3	0	67.3	8.6	12.3	5.6	22.9	0.1	5.6	10	4.4	0	4.2	4.2	22.2	0.1	3.1	2.6	31.5	9.1	7.6	1.2	1.7	12.4	2.1	2.8	1.2	2.2	2.9	0.8	3.2	1.2	3.3	2.5	3	4.1	1.4	2.7	12.7	0.8	13.2	5.1	1.4	4.5	0	0	2.7	0	32.2	0.1	93.4	0	0	3	377	54.1	3.6	19.6	20.7	27.5	0	0	77.3	18.7	0.4	6.1	35.5	10.1	9	0	0	7.2	0	4.2	0	1.3	12.9	33.1	0	0.7	9.4	28.9	8.2	0	1.7	Extravillous trophoblasts
CLDN19		ENSG00000164007	Claudin 19	Q8N6F1	1	42733093-42740254	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Sensory transduction, Vision		Disease mutation, Primary hypomagnesemia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	9	brain: 13.8;kidney: 22.5;placenta: 20.9;retina: 37.0	Cell type enriched	Detected in some	7	Extravillous trophoblasts: 192.3	Cancer enhanced	Detected in some		testis cancer: 2.6	Group enriched	Detected in some	54	midbrain: 13.8;pons and medulla: 9.5	Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Group enriched	Detected in some	5	CACO-2: 5.1;Hep G2: 10.6;SuSa: 6.4	Region enhanced	Detected in some		olfactory region: 6.7	Low region specificity	Detected in all																unprognostic (6.23e-4)	unprognostic (1.80e-1)		unprognostic (1.85e-6)	unprognostic (5.30e-2)	unprognostic (1.73e-1)	unprognostic (3.21e-2)	unprognostic (3.22e-1)	unprognostic (9.45e-2)	unprognostic (1.95e-1)	unprognostic (2.68e-1)	unprognostic (7.22e-2)	unprognostic (8.76e-3)	unprognostic (1.08e-1)	unprognostic (1.12e-1)		unprognostic (3.29e-3)	1	0.2	0.1	0.1	0.2	0.2	1.6	0.2	0.1	0.2	0.1	0.2	0	0.2	0.2	0.9	0.6	0.3	0.1	0.4	0.2	0.1	22.5	0.2	0.2	0.1	13.8	0	0.2	0.2	0.1	0.2	20.9	9.5	0.4	0.1	37	1.2	2.7	0.4	0.8	0.3	1	6.2	0.1	0.5	0.2	0	1.3	0.1	2.6	0.1	0.8	1	0.5	0.4	1.4	0.3	0.2	0.5	0.1	0	0	0	0	0.1	0	1.3	0	0	0	0	5.1	0	0	0	0	0	0	0	0	0	0	0	0	0.2	10.6	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0.1	0	0	0	0	6.4	0	0	0	0	0	0	0	0.1	0	0	0	0	0	1	0.3	0.3	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.5	0.5	0.5	1.4	0.2	0.2	0.4	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	13.8	0	9.5	0	0	0	0	0.2	0	0.2	0.3	0	0	1.2	12.2	0	9.1	28.2	0	0	0	0	0	0	192.3	0.2	0.1	0	0	4.4	0	0	0.6	0.6	0	0	0.4	0	0	0	0	0	0	0	1.9	0.1	0	0	0	0.1	0	10.4	0	0	0	Extravillous trophoblasts
TLX3	HOX11L2, RNX	ENSG00000164438	T cell leukemia homeobox 3	O43711	5	171309284-171312134	Cancer-related genes, Predicted intracellular proteins, Transcription factors		Developmental protein, DNA-binding	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	59	brain: 46.6	Cell type enriched	Detected in some	5	Extravillous trophoblasts: 5.2	Cancer enhanced	Detected in some		cervical cancer: 1.7	Region enriched	Detected in some	22	cerebellum: 46.6	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	SH-SY5Y: 24.6	Region enriched	Detected in single	7	cerebellum: 2.5	Region enriched	Detected in some	10	cerebellum: 48.1	HPA030504, HPA060957, HPA069359	Enhanced		Enhanced	Nucleoplasm						Nucleoplasm		HPA030504: AB_2732458, HPA060957: AB_2732655, HPA069359: AB_2732130		unprognostic (3.52e-2)		unprognostic (2.43e-2)					unprognostic (2.09e-1)	unprognostic (3.11e-1)				unprognostic (9.80e-2)	unprognostic (2.76e-2)		unprognostic (4.48e-2)	0.4	0.5	0	0	0	0	0	46.6	0	0.3	0	0	0	0	0	0	0.4	0	0	0.3	0	0	0.1	0	0	0	0	0	0	0	0	0.2	0.4	2	0	0	0	0	0	0	0	0.7	0	1.6	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0	0	4.5	0	0	0	0.3	0	0	0	1.3	0	4.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	0	0.2	0	0	24.6	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	46.6	0	0	0	0	0	2	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	5.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0	0	0	Extravillous trophoblasts
OXGR1	aKGR, GPR80, GPR99, P2RY15, P2Y15	ENSG00000165621	Oxoglutarate receptor 1	Q96P68	13	96985719-96994730	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		kidney: 7.0	Cell type enriched	Detected in some	11	Extravillous trophoblasts: 35.1	Low cancer specificity	Detected in many							Group enriched	Detected in some	5	myeloid DC: 2.9;plasmacytoid DC: 5.2	Lineage enriched	Detected in single	6	dendritic cells: 5.2	Cell line enhanced	Detected in some		RT4: 7.8;SK-BR-3: 3.6;T-47d: 1.7;U-2 OS: 4.1	Low region specificity	Detected in some			Not detected	Not detected			HPA067673			Supported	Plasma membrane						Plasma membrane		HPA067673: AB_2685883	unprognostic (1.83e-1)	unprognostic (1.01e-2)	unprognostic (1.33e-1)	unprognostic (6.97e-4)	unprognostic (7.23e-2)	unprognostic (1.52e-1)		unprognostic (8.38e-2)	unprognostic (2.16e-1)	unprognostic (1.16e-1)	unprognostic (2.22e-2)	unprognostic (4.14e-2)	unprognostic (3.88e-2)	unprognostic (1.89e-1)	unprognostic (2.75e-1)	unprognostic (1.54e-1)	unprognostic (9.68e-2)	2.1	0	0.7	1.7	0.2	0	6.7	0	2	1.6	3			0.1	0.6	4	3.2	2.5	0	0	0.8	0.8	7	0	0.5	0	0.7		0	0.6	0	0.3	1.2		0.5	2.4		4.9	0.3	0.1	4.3	0.5	0.5	1.6	0.3	0.1	0			0.8		0.9	1.8	0.9	0	5.2	0.1	0.5	0	0.8	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0	0	0	0.5	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0.7	0	0	0	0.3	0	0	0	0.2	0	7.8	0	0.2	0	3.6	0	0.2	1.7	0	0	0	4.1	0	0.2	0.2	0	0	0.2	0	0.3	0	0.5	0.1	0	0.1	0.8	0	0	0	2.9	0	0.1	0	0.1	0	0	5.2	0	0.1											0	0.3	0	0	0	0	0.1	0	1.4	0	0	0	1.1	1.7	0	0.2	0.1	0	0	0	35.1	0.1	0	0	0	1.6	0	1.2	0	0	0	0	0	3.3	0	0.3	0	0	0	0	0	0	0	0.1	0	0	0	3.1	0	0.8	0	Extravillous trophoblasts
LAIR2	CD306	ENSG00000167618	Leukocyte associated immunoglobulin like receptor 2	Q6ISS4	19	54497879-54510687	CD markers, Predicted intracellular proteins, Predicted secreted proteins		Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	blood: 12.8;lymphoid tissue: 19.6;pituitary gland: 7.1;placenta: 15.5	Cell type enriched	Detected in some	9	Extravillous trophoblasts: 233.4	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enriched	Detected in some	4	T-reg: 12.8	Lineage enriched	Detected in single	21	T-cells: 12.8	Group enriched	Detected in some	5	BEWO: 6.9;Hep G2: 3.3														Secreted - unknown location								unprognostic (1.99e-3)	unprognostic (7.49e-2)	unprognostic (4.19e-2)	unprognostic (1.02e-2)	unprognostic (1.42e-1)	unprognostic (4.86e-4)	unprognostic (1.06e-2)	unprognostic (8.37e-2)	unprognostic (1.16e-1)	unprognostic (3.93e-1)	unprognostic (2.21e-1)	unprognostic (9.52e-2)	unprognostic (3.68e-9)	unprognostic (1.21e-2)	unprognostic (3.15e-3)	unprognostic (3.40e-5)	unprognostic (6.71e-2)	0.9	0.5	0.6	5.9	1.7	1.6	0.5	0.2	1.3	0.4	0.6	1.3	0	0.4	0.5	1.3	0.7	0.5	1.3	0.4	1.4	3	0.6	0.8	3.2	12.3	0.6	0.5	0.2	0.9	0.1	7.1	15.5	1.3	0.8	1.3	0.4	0.5	0.4	0.6	0.5	1.2	0.5	1.5	6.6	1	1.2	0.4	19.6	0.5	0	2	0.3	0.3	0	0	0.1	0.1	0.6	12.8	1.8	0	0	0	0	0	0	6.9	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0.1	0	0.2	0	3.3	0	0.3	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0.6	0	0	0	0	0	0	0	0	0.1	0	0	0	0.3	0.5	0	0.4	0	0	0.3	0	0	0.7	0.3	0.1	0	1.1	0	0	0.1	0	0.2	0	0.4	0	3	2	0	0	0.8	2.7	0.1	0.6	0.1	0	12.8	1.8	0.6	1.7	0.2	1.3	1.4	3	0.6	0.5	1.3	0.4	0	0.3	0	0	0.1	0	0	0	0	0	0	0	8.1	0	0	0.1	0	0	0	0.2	233.4	0.5	0	0	0	21.7	0	0	0	0.3	0	0	0	1.7	0	0	0	0.5	0	0	0	0	0	0	0	0.2	0.1	26.9	24.5	0	0	Extravillous trophoblasts
HTRA4	FLJ90724	ENSG00000169495	HtrA serine peptidase 4	P83105	8	38974164-38988662	Enzymes, Predicted secreted proteins		Hydrolase, Protease, Serine protease		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	13	placenta: 55.2	Cell type enriched	Detected in some	9	Extravillous trophoblasts: 319.8	Cancer enhanced	Detected in some		testis cancer: 2.5	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enriched	Detected in some	23	BEWO: 72.8	Region enhanced	Detected in some		hippocampal formation: 2.3	Low region specificity	Detected in some			HPA045402	Enhanced				Secreted in female reproductive system							HPA045402: AB_2679316	unprognostic (1.20e-1)	unprognostic (5.83e-4)	unprognostic (8.02e-2)	unprognostic (2.13e-2)	unprognostic (8.20e-2)	unprognostic (2.42e-2)	unprognostic (1.80e-1)	unprognostic (7.40e-3)	unprognostic (1.40e-1)	unprognostic (5.14e-4)	unprognostic (1.01e-1)	unprognostic (8.68e-2)	unprognostic (1.42e-1)	unprognostic (4.58e-1)	unprognostic (5.19e-3)	unprognostic (2.39e-3)	unprognostic (1.19e-3)	2.6	1.1	0.2	0.3	0.2	3.4	0.9	0.2	0.4	1.2	0.5	0.2	1.9	0	2.3	0.5	0.5	0.1	0.2	0.2	0.2	0	0.2	0.2	4.3	1	0.2	0.2	0.4	0.3	0.4	0.5	55.2	0.4	0.5	0.3	1.8	0.8	0.5	0.6	0.4	0.6	0.3	1.8	2.5	0.1	0.4	0.2	0.2	0.6	0.2	0.8	0.5	0.9	3.1	2.2	2.5	1	1	1.7	0	0.1	0.1	0.1	0.2	0.3	0.2	72.8	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0	0.3	0.2	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0	0.2	0.2	0.3	0.1	0.1	0.5	0.1	0.1	0	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0	3.1	0.1	0.2	0	0.3	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	1.5	0.8	2.3	1.4	0.7	1.7	1.5	1.3	1.2	0.6	3.1	1.3	1.4	2.5	1	1	2.2	1.4	0	0.2	0.2	0.2	0.4	0.2	0	0.2	0.2	0.4	0.2	0	0	0	1.1	0.1	0.5	0.4	0	0	0	0	2	2.1	0	0	0	0.1	0	0	0	319.8	0.2	1.2	0	0	10.7	1.6	0	2.5	0.3	0	0	1.5	1.7	0	0	0.6	0.2	0	0	0	0.1	0	0	0	0	0.1	33.8	0	0.2	0.7	Extravillous trophoblasts
WNT10B	SHFM6, WNT-12	ENSG00000169884	Wnt family member 10B	O00744	12	48965340-48971763	Disease related genes, Predicted secreted proteins	Wnt signaling pathway	Developmental protein	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 23.4	Cell type enriched	Detected in some	11	Extravillous trophoblasts: 12.8	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Cell type enhanced	Detected in some		gdT-cell: 1.6	Lineage enriched	Detected in single	17	T-cells: 1.6	Cell line enhanced	Detected in many		K-562: 8.1;T-47d: 9.7;U-266/84: 8.7	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA055048, HPA062539	Enhanced		Approved	Golgi apparatus	Secreted to extracellular matrix					Golgi apparatus		HPA055048: AB_2682683, HPA062539: AB_2684793	unprognostic (1.13e-1)	unprognostic (2.14e-2)	unprognostic (5.73e-4)	unprognostic (2.27e-2)	unprognostic (3.09e-2)	unprognostic (3.33e-2)	unprognostic (6.08e-2)	unprognostic (1.38e-1)	unprognostic (2.12e-1)	unprognostic (1.14e-1)	unprognostic (4.99e-3)	unprognostic (3.05e-2)	unprognostic (5.39e-6)	unprognostic (4.29e-2)	unprognostic (3.74e-2)	unprognostic (4.50e-1)	unprognostic (1.25e-1)	2.3	0.6	10.9	2.6	23.4	2.1	1.8	0	14.3	0.5	1.7	0.5	3	2.8	0.4	3.2	1.5	0.6	1.1	1.2	7.3	4.9	0.2	0.3	1.3	3	3	7.2	1.2	0	0.1	1.1	7	4.1	1	1.6	0.7	1.7	1.4	1.6	5	3.3	2	0.8	2.9	2	1.7	0.3	0.2	0.5	1.2	2.9	1.8	1.6	0	0	0	0	0	1.6	0.2	2.1	1.4	0	2	0	0	5.4	1.5	2.8	0.6	0.2	4.2	4.7	0	0.4	0.3	1.8	2.6	5.6	0.4	0.2	1.2	7.4	2.4	1.8	0.1	0	0.8	3.5	0	0.4	0.1	2.5	4.9	0	1.8	8.1	0.3	0.8	2.8	0.1	2.8	0	1.5	3	0	0.7	2.6	0	0.5	0.1	0	0.3	0.2	0.7	2.8	9.7	3.1	0	3.1	6	0.4	0.7	3.1	8.7	0	1.2	6.2	0.2	0	0	0	1.6	0	0.9	0	0	0.5	0	0	0.7	1	0	0	0	0	0	0.2	10.9	23.4	0	13.9	7.3	4.9	3	7.2	4.1	0.3	0	0	0	0	0.3	0	0.3	0	0	0	0	0	0.2	0	0	0.7	0	0	0	0	12.8	0.7	0	0	0	0.3	0	0	0.6	0	0.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.4	1.1	1.1	0.9	0	0	Extravillous trophoblasts
HASPIN	GSG2	ENSG00000177602	Histone H3 associated protein kinase	Q8TF76	17	3723903-3726699	Enzymes, Predicted intracellular proteins	Cell cycle	Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	bone marrow: 7.5;lymphoid tissue: 26.7;testis: 26.7	Cell type enriched	Detected in single	5	Extravillous trophoblasts: 2.7	Low cancer specificity	Detected in many			Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			HPA027422, HPA030698	Approved		Supported	Nucleoplasm						Nucleoplasm		HPA027422: AB_10601812, HPA030698: AB_2673575	unprognostic (1.15e-2)	unprognostic (2.78e-2)	unprognostic (7.06e-2)	unprognostic (2.14e-2)	unprognostic (8.05e-2)	unprognostic (2.81e-1)	unprognostic (1.01e-4)	unprognostic (1.57e-2)	unprognostic (6.60e-2)	unprognostic (1.77e-1)	unprognostic (2.75e-3)	unprognostic (3.82e-3)	unprognostic (0.00e+0)	unprognostic (5.65e-3)	unprognostic (3.09e-2)	unprognostic (1.31e-1)	unprognostic (1.73e-1)	1.2	0.3	0.3	11.8	0.6	7.5	1.8	0.5	0.3	0.5	1.5	0.2	0	2.2	0.3	0.4	2.8	0.6	1.3	0.6	0.2	0.2	0.8	0.4	2.6	5.8	0.4	0	0.4	0.5	0	0.3	1.3	0.2	0.7	1.5	0.2	1	0	1.2	0.9	3.6	0.4	1.2	4.9	1.7	26.7	0.3	26.7	0.7	1.7	7.3	0.8	1	2.8	1.5	2.1	0.6	0	1.2	0.4	7.5	8.3	7.7	8.6	0.5	1	6.4	7	5.3	13.8	13.6	6.5	3.1	18.6	4	3.8	5.5	12.3	13.8	6.7	13.2	0.1	11.5	9.2	6.7	3.8	0.3	5.3	9.5	0.6	0.5	10.3	6.4	1.6	6.3	14.8	8.1	16.4	6.9	3.9	10.7	3.1	6.7	5.8	5.7	11.2	9.7	5	2	5.3	3.1	4.5	6.1	4.2	2.4	7	4.2	5	3.2	6.1	7	6.8	12.1	3.1	3.5	9	3.6	7.7	7.3	0.4	0.6	2.1	0.2	0.5	0.2	0.7	0.8	0	1.1	2.8	1.2	0.2	0.2	0	0	1.5	0.1	0.4	0.3	0.6	0.5	0.3	0.2	0.2	0.4	0	0.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	2.7	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0	0	Extravillous trophoblasts
NOG	SYM1, SYNS1	ENSG00000183691	Noggin	Q13253	17	56593699-56595590	Disease related genes, Predicted secreted proteins	Chondrogenesis, Differentiation	Developmental protein	Deafness, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 32.8;placenta: 37.1;retina: 18.6	Cell type enriched	Detected in single	11	Extravillous trophoblasts: 8.9	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Group enriched	Detected in some	12	naive CD4 T-cell: 32.8;naive CD8 T-cell: 15.1	Lineage enriched	Detected in single	81	T-cells: 32.8	Cell line enhanced	Detected in some		EFO-21: 51.0;LHCN-M2: 15.5;NB-4: 11.3;PC-3: 15.4;U-2 OS: 15.8	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA061318	Approved				Secreted to blood							HPA061318: AB_2684478	unprognostic (1.49e-1)	unprognostic (1.17e-2)	unprognostic (1.49e-5)	prognostic favorable (6.66e-4)	unprognostic (4.69e-2)	unprognostic (5.23e-3)		unprognostic (1.26e-2)	unprognostic (3.06e-1)	unprognostic (3.02e-1)	prognostic unfavorable (6.86e-5)	unprognostic (2.88e-1)	unprognostic (1.14e-6)	unprognostic (8.39e-2)	unprognostic (1.40e-1)	unprognostic (5.00e-1)	unprognostic (1.65e-1)	0.9	0.3	4.9	2	7.2	0.7	0.5	0.9	8.3	5.5	0.6	1.8	0.4	0.5	0.8	6.3	0.4	0.4	0.3	0.4	3.8	3.1	0.8	0.4	1	3.3	1.9	2.7	0.3	0.5	0.3	0.8	37.1	1.1	1.4	0.4	18.6	0.4	2.9	3.6	0.4	0.7	0.5	0.8	1.5	0.8	1.6	1.8	1.7	0.3	0	1.1	0.9	3.1	0	0.1	0.4	0.1	0.2	32.8	1.7	2.4	0	0.1	0	0.1	0	0	1.3	1.4	0.5	0.5	0.1	0.4	0	51	0.6	2	0.2	0.8	0.1	1.4	0	0.9	0	1.9	0	0	0.3	0	0.2	0.2	0	0.2	0.1	0	0	0	0	15.5	0	0.4	11.3	1	0	15.4	6.7	4.7	0	1.2	0	0.1	0	2.6	0	0	4.3	0	0.2	0.3	0.9	15.8	0.1	1.1	0	0	0.1	0	1.2	0	0.3	0	0.1	0.2	0.1	0.1	0	1.9	0.2	0	0	32.8	15.1	0.4	0.2	0.1	0.1	1.3	1.7	4.9	7.2	0.9	2.5	3.8	3.1	1.9	2.7	1.1	1.8	0	0	0	0.2	0	0	0.8	0	0	0	0	0	0.1	0	0.2	0.1	0	0	0	0	8.9	0.6	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.2	0	0	0.4	0	0	0.1	0.7	0	0	0	Extravillous trophoblasts
LHFPL6	LHFP, MGC22429	ENSG00000183722	LHFPL tetraspan subfamily member 6	Q9Y693	13	39342892-39603528	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in some	8	Extravillous trophoblasts: 146.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	9	myeloid DC: 9.4;plasmacytoid DC: 3.2	Lineage enriched	Detected in single	14	dendritic cells: 9.4	Cell line enhanced	Detected in many		ASC diff: 66.1;HSkMC: 48.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA058975	Approved		Approved	Nucleoli						Nucleoli		HPA058975: AB_2683866	unprognostic (6.98e-2)	unprognostic (2.71e-1)	unprognostic (2.00e-2)	unprognostic (1.53e-1)	unprognostic (1.13e-2)	unprognostic (4.10e-2)	unprognostic (5.84e-2)	unprognostic (1.08e-1)	unprognostic (2.76e-1)	unprognostic (5.45e-2)	unprognostic (8.68e-2)	unprognostic (1.90e-2)	prognostic unfavorable (1.20e-7)	unprognostic (4.41e-3)	unprognostic (5.25e-2)	unprognostic (7.75e-2)	prognostic unfavorable (2.30e-4)	57.2	26.8	12.5	14.8	17.7	0.9	45.7	40.8	19	20.3	16.4	12.3	8.5	5.3	28.6	23.7	17.9	27	34.9	49.4	12.7	12.9	12.8	6.9	27	27.4	19.3	12.6	25.7	8.3	7.1	14.3	62	16.8	21.4	8.4	19.8	11.4	18.8	13.6	13.1	9.6	33.1	18.5	18.5	10.2	16.2	11.9	1.3	22.7	22.1	8.3	20.1	25.8	0.2	9.4	0.1	0.6	0	0	0.4	2.7	1	30	1.3	66.1	30	13.1	15.3	22.1	7.8	5.9	0.1	2.9	4.2	0.3	21.3	10.2	4.3	3.7	8.9	6.5	4.1	4.4	11.5	0.9	0	6.9	0.2	0.3	48.3	1.2	7	11.7	7	7.2	0.2	0	0	15	2.4	0	3.5	2.2	0	4	1.8	13	0	5.2	3.7	0.1	0.9	1.4	1.8	4.1	17.9	1.7	0	13.5	19.9	2.9	6.1	8.3	0.2	0	12	8.3	0	14.3	0	0.5	0	0	0.6	0	0	0	0	9.4	0.2	0	0	0.1	0	0.1	3.2	0	0.4	12.5	17.7	40.8	19	12.7	12.9	19.3	12.6	16.8	11.9	3	9.8	0	0	0	0	0	0	4	18.2	0	0	3.1	1.7	0.6	0	0	0	0	0.6	146.6	0	0	2.3	0	4.6	0	0	0	0	0	0	0.7	0	0	0	0	0.7	0	0	2.4	0	0	0	0	0	0	5.1	0	0	0	Extravillous trophoblasts
ASCL2	ASH2, bHLHa45, HASH2	ENSG00000183734	Achaete-scute family bHLH transcription factor 2	Q99929	11	2268495-2270952	Predicted intracellular proteins, Transcription factors	Differentiation, Neurogenesis	Developmental protein, DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		ductus deferens: 21.8;placenta: 16.0	Cell type enriched	Detected in many	12	Extravillous trophoblasts: 947.6	Group enriched	Detected in many	5	colorectal cancer: 76.1;stomach cancer: 23.1	Low region specificity	Detected in many			Cell type enhanced	Detected in many		eosinophil: 8.6	Low lineage specificity	Detected in many			Group enriched	Detected in some	5	BEWO: 18.5;NB-4: 5.4;OE19: 10.0;SCLC-21H: 15.1	Not detected	Not detected			Low region specificity	Detected in some																unprognostic (2.71e-3)	prognostic favorable (5.11e-4)	unprognostic (2.03e-1)	unprognostic (2.33e-2)	unprognostic (1.72e-1)	unprognostic (2.69e-2)	unprognostic (2.93e-2)	unprognostic (7.88e-2)	unprognostic (3.79e-2)	unprognostic (1.22e-2)	prognostic favorable (4.73e-4)	unprognostic (5.85e-2)	unprognostic (1.45e-6)	unprognostic (8.86e-3)	unprognostic (5.48e-2)	unprognostic (6.12e-4)	unprognostic (1.07e-3)	0.5	0.3	0.7	2.2	1.3	0.9	1.1	0	1.2	2.7	7.3	1.4	21.8	9.2	3.6	1.2	2.5	0.7	0.4	0.8	0.6	0.4	2.5	1.1	0.9	0.9	1.5	0.6	0.4	1.5	0	0.1	16	1.1	3.3	3.4	0.1	9.7	9.5	0.6	10	7.3	0.2	3.7	3	2.8	1.6	1.1	1.1	0.7	0.8	2.7	3.6	3.3	0.1	1	8.6	2	0	3	0.3	0	0	0.2	0	0	0	18.5	0	0	0	0	2.5	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	2	0	0	0	0	0	1.7	0	0	1.9	0	5.4	0.4	10	0	0	0	0	0	0.4	15.1	0	0	0.3	0	0	1.9	1.2	0	0	0	0	0	0	0	0	0	0.8	0	4.5	1.4	8.6	3	2	0.2	0.1	0.7	1.7	1	0	0.2	1.7	1.2	0	1.7	0	0	0.3	0.7	1.3	0	1.2	0.6	0.4	1.5	0.6	1.1	1.1	0	0	1.9	12.4	12	0	0.8	0	1.4	0	19.2	0	15.5	6.6	0.1	0	0.7	6.8	0	0	947.6	0.8	3.8	0	0.2	28.4	0	75.2	20.3	18.4	0	1.7	8.5	1.7	1	19.5	0	0	3.4	1.4	0.3	0	0	0.3	0.3	11.3	4.1	19.5	8.5	77.9	4.6	Extravillous trophoblasts
NOTUM		ENSG00000185269	Notum, palmitoleoyl-protein carboxylesterase	Q6P988	17	81952507-81961840	Enzymes, Predicted intracellular proteins, Predicted secreted proteins	Wnt signaling pathway	Hydrolase, Serine esterase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	12	placenta: 127.4	Cell type enriched	Detected in some	47	Extravillous trophoblasts: 865.2	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	Hep G2: 96.3	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA022851			Approved	Endoplasmic reticulum	Secreted in female reproductive system				59000	Endoplasmic reticulum		HPA022851: 	unprognostic (1.49e-1)	unprognostic (1.55e-1)	unprognostic (1.23e-2)	unprognostic (4.80e-3)	unprognostic (1.97e-1)	unprognostic (9.02e-3)	unprognostic (3.01e-2)	unprognostic (1.01e-2)	unprognostic (6.49e-2)	unprognostic (8.72e-2)	unprognostic (1.40e-1)	unprognostic (2.01e-2)	unprognostic (4.48e-6)	unprognostic (1.76e-1)	unprognostic (9.88e-2)	unprognostic (1.22e-3)	unprognostic (1.00e-1)	0.2	0.1	1.1	0.2	1.2	0.1	0.2	0.3	1	0.2	0.2	0.2	0.5	0.6	1	1.3	0.3	0.2	0.3	0.3	0.5	0.9	0.8	10.4	1.8	0.2	0.7	0.4	0.2	0.2	0	0.2	127.4	0.6	0.4	0	0.2	0.3	0.2	4.9	2.4	0.2	0.2	0.3	0.3	0.9	3	0.5	0.2	0.2	0.3	0.2	1.3	1.3	0.7	0	0	0	0	0.4	0.5	0	0.2	0	0	0	0	0.3	0	0	0	0	2.2	0.1	0	0.4	0	0	0.1	0.5	0	0	0	0.2	0.5	0.6	96.3	0	0.1	0	0	0	0	0	0.1	0	0	2.5	0	0	0.1	0	0	0	15.6	0.1	0	0	0	0	0	3.7	0.3	0.9	0.4	1.4	0.5	0	1.1	0	0.1	1.5	0	0	0	0	0.3	0	0	0	0	0	0	0.2	0	0	0	0.4	0	0	0.7	0.1	0	0	0	0	0	0	0.5	1.1	1.2	0.3	1	0.5	0.9	0.7	0.4	0.6	0.5	0	3	0	0.1	0.1	0	1.1	0	0	0	0	0	8.8	0	0	0.1	0	0	0	0	865.2	2.3	0	0	0.9	17.2	0	0	0	0	0	0.3	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	9.8	0	18.4	0	0	0	Extravillous trophoblasts
NLRP9	CLR19.1, NALP9, NOD6, PAN12	ENSG00000185792	NLR family pyrin domain containing 9	Q7RTR0	19	55708432-55738402	Predicted intracellular proteins	Immunity, Inflammatory response, Innate immunity			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		prostate: 5.3	Cell type enriched	Detected in some	17	Extravillous trophoblasts: 21.1	Cancer enriched	Detected in single	59	testis cancer: 14.4					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 3.3;HEK 293: 1.0;Karpas-707: 1.2;U-266/84: 1.3					Not detected	Not detected			HPA042623	Uncertain											HPA042623: AB_10965692	unprognostic (2.50e-1)	unprognostic (3.03e-1)	unprognostic (1.74e-1)	unprognostic (2.85e-1)	unprognostic (8.82e-2)	unprognostic (6.53e-2)	unprognostic (9.92e-3)	unprognostic (1.63e-1)	unprognostic (9.55e-2)	unprognostic (3.68e-1)	unprognostic (1.17e-1)	unprognostic (1.40e-1)	unprognostic (4.56e-3)	unprognostic (2.73e-1)	unprognostic (3.46e-1)	unprognostic (9.56e-2)	unprognostic (8.09e-3)	0.1	0.2	0	0.2	0.5	0.7	0.1	0.5	0.1	0.1	0.3			0.2	0.4	0.7	0.1	0.4	0.2	0.1	0	0	1	0.9	0.4	0.2	0		0.7	0.8	0.1	0.6	0.1		5.3	0.1		0.1	0.2	0.1	0.4	1.2	0.1	0	0.9	2	1.9			0.2		0.1	0.1	0	0	0.2	0.7	0.2	0	0	0	0	0	0	0.1	0	0	3.3	0	0	0	0	0.1	0.1	0.2	0	0	0	0.2	0	0	0	0	1	0	0	0	0	0	0.2	0	0	0	0	0	0	0.6	0.2	1.2	0	0	0	0.1	0.2	0.2	0	0.1	0.9	0.6	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0.1	0.1	0	0.4	1.3	0.3	0	0.2	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0.2	0	0											0	0	0	0	0	0	0.4	0	0	0	0	0	0.3	0	0	0	0	0	0	0	21.1	0	0.2	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	1.3	0	0	0	Extravillous trophoblasts
MFAP5	MAGP2, MP25	ENSG00000197614	Microfibril associated protein 5	Q13361	12	8637346-8662888	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins			Aortic aneurysm, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		placenta: 128.1	Cell type enriched	Detected in many	4	Extravillous trophoblasts: 937.0	Low cancer specificity	Detected in many			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		BEWO: 50.0;BJ: 18.1;EFO-21: 43.9;HeLa: 16.6;SuSa: 42.1	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA010553	Enhanced				Secreted to extracellular matrix				3800000			HPA010553: AB_1853843	unprognostic (1.80e-1)	unprognostic (1.11e-2)	unprognostic (4.25e-2)	unprognostic (4.84e-2)	unprognostic (1.44e-1)	unprognostic (6.05e-2)	unprognostic (2.15e-3)	unprognostic (1.10e-1)	unprognostic (1.64e-1)	unprognostic (8.79e-2)	unprognostic (8.63e-3)	unprognostic (3.05e-1)	unprognostic (4.41e-7)	prognostic unfavorable (6.87e-4)	unprognostic (8.81e-2)	unprognostic (2.05e-2)	prognostic unfavorable (5.81e-4)	44.3	3.2	0.6	3.3	0.7	0.3	21.8	0.5	0.5	71.5	11.2	0.5	18.2	1.4	78.4	34	31.3	9	6.8	16.5	0.7	0.6	1.9	3	3.3	3.3	0.6	0.4	4.7	1.4	0.2	1.7	128.1	0.7	7.6	11	0.9	6	13.5	19.6	13	9	37	3.4	1	7.9	12.3	0.3	1	13.1	35	4.5	46.3	21.1	1.1	1.2	5.3	2.4	0.6	1.2	0.8	0.4	1.6	0.4	0.7	8.7	3.7	50	18.1	0.3	0.2	0.3	0.6	0.3	0.1	43.9	5.6	0.4	2.5	0.1	3.7	0	0.1	0.1	0.4	16.6	0.5	0.1	0.3	0.2	2.5	1.3	2.1	0	0.9	0	0.5	0.7	1	15.1	0.2	0.5	0.2	0.9	0.2	0.8	0.3	0.4	1.8	1.8	0.7	0.2	0.2	0.5	0.2	0.3	42.1	6.9	0.2	0.6	3.2	6.3	13.2	0.8	0.6	0.5	0.5	1.7	0.2	0	5.3	2.4	2	0.7	1.9	1.2	0.4	0.4	0.4	1.2	1.1	1.2	0.5	3.1	0.6	1.4	1	0.1	0.8	0.6	0.7	0.5	0.5	0.7	0.6	0.6	0.4	0.7	0.3	11.9	4.3	0	0.4	20.5	0.2	5.2	0	2.7	3.4	0	0	70.9	0	0	0.3	4.4	0	0	0	937	96.1	0	0	0	24.9	0	0	7.4	1.9	0.2	56.7	3.6	11.8	0	0	0.1	1.1	0	0	0	0.6	0	20.2	0	0	15.7	210.9	0	0	0.1	Extravillous trophoblasts
HLA-G		ENSG00000204632	Major histocompatibility complex, class I, G	P17693	6	29826967-29831125	Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins	Immunity		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	placenta: 66.0	Cell type enriched	Detected in many	15	Extravillous trophoblasts: 586.1	Low cancer specificity	Detected in all			Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Group enriched	Detected in some	4	CAPAN-2: 1.2;SuSa: 3.9									CAB016158	Enhanced				Secreted to blood			32800000				CAB016158: AB_627938	unprognostic (1.13e-2)	unprognostic (9.95e-2)	unprognostic (1.30e-1)	unprognostic (3.40e-2)	unprognostic (8.35e-2)	unprognostic (1.35e-1)	unprognostic (1.18e-3)	unprognostic (2.51e-1)	prognostic favorable (3.91e-5)	unprognostic (6.34e-2)	unprognostic (8.31e-2)	unprognostic (1.78e-1)	unprognostic (1.03e-2)	unprognostic (6.56e-3)	unprognostic (1.40e-1)	unprognostic (1.52e-2)	unprognostic (3.19e-3)	0.2	0.1	0	0.5	0.1	0.2	0.3	0.1	0.1	0.2	0.5	0.1	0	1.2	0.2	0.6	0.1	0.1	0.2	0.3	0.2	0	0.5	0.2	2.8	0.7	0.1	0.1	0.3	1.9	0.1	15.2	66	0.1	0.2	0.2	0.3	0.4	0.6	0.2	0.2	0.8	0.1	0.2	1.2	0.9	2.2	0.2	1.3	0.4	0.2	0.2	0.2	0.3	0.3	0.3	2.2	0.9	0.2	1.2	5.7	0.2	0	0	0	0.1	0	0	0	0.1	0	0.1	0	1.2	0.1	0	0	0.5	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0.2	0	0	0	0	0	0.2	0.2	3.9	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0.1	0.6	0.9	1.2	0.7	0.5	1.2	0.3	0.1	0.5	0.3	0.3	0.6	1.2	2.2	0.2	0.6	0.1	0.5	5.7	0	0.1	0.1	0.1	0.2	0	0.1	0.1	0.1	0.2	0	1.1	1.4	6.4	20.3	0	0.8	5.1	0	0	0	0	7.8	0	2.8	16.1	5.2	2.6	0	4.7	586.1	11.7	5.5	0	1.1	21.9	0	16.8	8	11	5.3	2.3	3.3	11.8	0	39.2	0	15.5	20.1	2.5	0.2	0	0	3.3	4.7	3	30.7	33.9	6.9	9.7	6.7	Extravillous trophoblasts
CATSPERZ	C11orf20, DKFZP566E164, TEX40	ENSG00000219435	Catsper channel auxiliary subunit zeta	Q9NTU4	11	64300391-64304770	Predicted intracellular proteins	Differentiation, Spermatogenesis			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	105	testis: 139.5	Cell type enriched	Detected in some	4	Extravillous trophoblasts: 29.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 5.7;CACO-2: 15.6;PC-3: 9.3;T-47d: 7.6									HPA052822			Approved	Nucleoplasm						Nucleoplasm		HPA052822: AB_2797245	unprognostic (1.89e-1)	unprognostic (7.81e-2)			unprognostic (1.88e-1)				unprognostic (8.23e-2)	unprognostic (2.18e-1)		unprognostic (1.11e-1)	unprognostic (5.66e-4)	unprognostic (5.96e-2)	unprognostic (3.07e-2)		unprognostic (1.43e-1)	0.1	0	0.5	0	0.4	0	0.8	0.1	0.9	0.2	0.1	0.1	0.2	0	0.1	0.7	0.1	0	0.2	0	0.5	0.2	0.1	0	0.2	0	0.1	0.2	0	0.1	0	0	1.3	0.1	0.3	0.1	0.3	0	0	0	0.2	0.1	0	0	0	0	139.5	0.1	0	0.4	0	0.1	0.1	0.2	0.5	0.4	0.6	0.6	0	0.3	0	0	4.1	0.3	0	0.5	1	5.7	0	0.3	0	0	15.6	3.2	0.1	0.2	0.2	0.2	3.4	3.2	0.5	0.1	0	0	1.5	0.1	1	0.1	0	0	0.1	0.3	1	0	0	0.2	0	1.6	0.7	0.2	0.7	0	0.7	1.1	4.5	9.3	1.7	0	2	4.5	1.5	0.1	0.9	1.7	0.5	0.2	0.3	7.6	0.4	0.3	0.2	0.1	2.1	0	0.4	0.1	0.5	0.3	0	0.1	0	0.3	0	0.3	0.2	0.1	0.5	0	0.2	0	0.1	0.1	0	0.6	0	0.6	0.4	0	0	0.5	0.4	0.1	0.3	0.5	0.2	0.1	0.2	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	3.3	0	0	0	0	0	0	0.4	29.2	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.3	0	0	0	0	0	0	7	0	0	0	Extravillous trophoblasts
RFPL4B	RNF211	ENSG00000251258	Ret finger protein like 4B	Q6ZWI9	6	112347330-112351296	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	5	testis: 8.0	Cell type enriched	Detected in some	8	Extravillous trophoblasts: 13.9	Group enriched	Detected in some	7	liver cancer: 0.6;testis cancer: 1.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ hTERT+: 1.5;K-562: 3.1;RPTEC TERT1: 4.1;U-266/70: 1.7;U-266/84: 12.7									HPA059324, HPA066464	Uncertain											HPA059324: , HPA066464: 	unprognostic (4.26e-1)				unprognostic (1.45e-1)						unprognostic (6.66e-2)	unprognostic (3.78e-1)	unprognostic (2.80e-3)		unprognostic (3.73e-2)			0.2	0	0	0	0.3	0	0	0	0.4	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0.5	0	0	0	0	0.9	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0.1	0	0	0	8	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.3	0	0	0.1	1.5	0	0	0	0.2	0	0.2	0.8	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	3.1	0	0	0	0	0	0	0	0	0	0	0	4.1	0	0.1	0	0.1	0	0	0	0	0	0	0.2	0.1	0.1	0	1.7	12.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0.4	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0	0	13.9	0.2	0	0	0	0.2	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.4	0	0	0	0	1.7	1.4	0	0.3	0	0	0	Extravillous trophoblasts
MMP12	HME	ENSG00000262406	Matrix metallopeptidase 12	P39900	11	102862736-102875034	Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins		Hydrolase, Metalloprotease, Protease	Cancer-related genes, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		lymphoid tissue: 42.4;urinary bladder: 13.2	Cell type enriched	Detected in some	5	Extravillous trophoblasts: 80.4	Low cancer specificity	Detected in all							Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	12	BJ: 4.2;fHDF/TERT166: 14.6;hTEC/SVTERT24-B: 8.4	Not detected	Not detected			Not detected	Not detected								Secreted to extracellular matrix								unprognostic (7.33e-2)	unprognostic (3.20e-2)	unprognostic (1.00e-2)	unprognostic (1.03e-1)	unprognostic (2.74e-1)	unprognostic (1.67e-1)	prognostic unfavorable (1.42e-4)	unprognostic (1.69e-2)	unprognostic (7.31e-2)	unprognostic (1.52e-2)	unprognostic (1.52e-3)	unprognostic (5.45e-2)	unprognostic (3.05e-6)	unprognostic (1.08e-2)	unprognostic (4.66e-2)	unprognostic (1.73e-1)	unprognostic (6.92e-2)	2.7	0	0	21.2	0	0	0	0	0	0.3	6.9	0	0	3.3	0	5.9	0	0	1	0	0		0	0.4	0.6	18.9	0	0	0.1	0	0	0	9.7	0	0.3	8.4	0	0.9	0	0	0	3.8	4.6	0	42.4	1.3	0.1	0	5.5	0	1.5	9.9	13.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.2	0.4	0.2	0	0.1	0	0	0	14.6	0.1	0.5	0	0	0.4	0.4	0.3	0	0	0	0	0	0	0	0	8.4	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0.4	0	0	0	0.5	0	0.1	0	0	0	0.5	0.6	0.2	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0.8	0	0	0	0	0	0	0	0	1.1	0	1	0	0	0	0	17	80.4	0	0	0	0	15	0	0	0	0	0	0	0	0	0	0	0	4.2	0	0	0	0	0	0	0	0	0	3.8	0	0	1.4	Extravillous trophoblasts
